BioSpace News Archive

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its inclusion in the Dow Jones® Sustainability World Index (DJSI World) as one of the world’s leading companies for sustainability.

Benitec Biopharma Inc. today announced the financial results for its Fiscal Year Q1 ended September 30, 2021.

Memic Innovative Surgery Ltd. announced the expansion of its management team with the appointments of four seasoned executives, including Duncan Moffat as executive vice president of corporate operations, Chad Zaring as chief commercial officer, Stavit Cohen as vice president of research and development and Gus Castello as principal operations advisor.

Diadem srl, today reported that it presented extensive data at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) meeting showing that its AlzoSure® Predict prognostic biomarker test is accurate in identifying individuals with few or no cognitive symptoms who will decline to AD up to six years before diagnosis.

Twist Bioscience Corporation (NASDAQ: TWST), today announced it has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody, discovered and optimized by Twist Biopharma, a division of Twist Bioscience, that neutralizes all known variants of concern of the SARS-CoV-2 virus in preclinical studies.

Today, Thimble Point Acquisition Corp, Inc. and Pear Therapeutics, Inc. jointly announced an additional commitment from an affiliate of Thimble Point’s sponsor of up to $50 million.

Celcuity Inc. today announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer to provide Ibrance (palbociclib) for use in Celcuity’s Phase 3 clinical trial at no cost to Celcuity.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today reported financial results for the third quarter of 2021 and summarized recent business highlights.

Kintara today announced financial results for its fiscal first quarter ended September 30, 2021 and provided a corporate update.

Nanomix Corporation today announced the completion of its name change from Nanomix, Inc. to Nanomix Corporation and its ticker symbol from “BTHE” to “NNMX”.